VRDN 240920 20.00C (VRDN240920C20000) Stock Options, News & Quotes

US OptionsDetailed Quotes

VRDN240920C20000

Watchlist

2.20
+1.10+100.00%

15min DelayClose Sep 13 16:00 ET

2.25High1.80Low

Intraday

5D
Daily

News

Wedbush Maintains Viridian Therapeutics(VRDN.US) With Buy Rating, Raises Target Price to $45
Moomoo NewsSep 13 12:31 ET · Ratings
Wedbush Raises Viridian Therapeutics' Price Target to $45 From $42, Maintains Outperform Rating
MT NewswiresSep 13 11:48 ET · Ratings
Viridian Therapeutics Analyst Ratings
BenzingaSep 13 09:53 ET · Ratings
RBC Capital Maintains Viridian Therapeutics(VRDN.US) With Buy Rating, Raises Target Price to $44
Moomoo NewsSep 13 07:33 ET · Ratings
Buy Rating Affirmed for Viridian Therapeutics Following Positive THRIVE Study Results and Strong Market Potential for Veli
TipRanksSep 13 01:58 ET · Ratings
Express News | Viridian Therapeutics Inc : RBC Raises Target Price to $44 From $35
ReutersSep 13 01:53 ET

Comments

MitchBrannon

Sep 10 15:30

$Viridian Therapeutics (VRDN.US)$ bought pullback at 18.1
somehow lost on $NIO Inc (NIO.US)$ earlier but we can't stop won't stop 😂😭

Trytosaveabit

Sep 10 15:03

News

$Viridian Therapeutics (VRDN.US)$ Viridian Therapeutics Announces Proposed Underwritten Public Offering of Common Stock and Preferred Stock
2 MINUTES AGO, 4:01 PM EDT
VIA BUSINESSWIRE

Stock_Drift

Sep 10 08:05

9/10/24_👀’s On. 🚨🚨🚨🚨 *not trading or financial advice*

$SMX (Security Matters) (SMX.US)$ $BIO-key International (BKYI.US)$ $Silexion Therapeutics (SLXN.US)$ $BloomZ (BLMZ.US)$ $Viridian Therapeutics (VRDN.US)$
📊⚡️📊

Jaguar8

Sep 10 07:00

NEWS

$Viridian Therapeutics (VRDN.US)$
Viridian Therapeutics Announces Positive Topline Results from Veligrotug (VRDN-001) Phase 3 THRIVE Clinical Trial in Patients with Active Thyroid Eye Disease
Viridian Therapeutics (NASDAQ: VRDN) announced positive topline results from the THRIVE Phase 3 clinical trial of veligrotug (VRDN-001) in patients with active thyroid eye disease (TED). The trial met all primary and secondary endpoints, showing significant improvements in proptosis, diplopia, and clinic...

Alvinnnnnnngenius

Mar 8, 2023 08:34

Good stock

$Viridian Therapeutics (VRDN.US)$